NEWS
LIONEX DIAGNOSTICS AND THERAPEUTICS
LIODetect TBST®
The TB Rapid test of LIONEX has shown excellent results in a study published in the International Journal TUBERCULOSIS
LIODetect TBST® publication in International Journal with excellent results
IGRA/IGRA-TB
LIOFeron®TB/LTBI
LIONEX has introduced a new IGRA test for Tuberculosis and Latent Tuberculosis Infection (LTBI called LIONEX®TB/LTBI
LIOFERON publications in peer-reviwed International Journals with excellent results
EndoTrap®
The complete EndoTrap® product range as well as EndoGrade® Ovalbumin have been discontinued by Hyglos as of 31 December 2017, instead LIONEX GmbH, Braunschweig, Germany, is now the manufacturer and exclusive supplier of these products.
EndoTrap® family: Endotoxin removal products are now available from LIONEX, Braunschweig, GERMANY
LIOSpot®TB human
LIONEX has developed a new ELISPOT test which, for the first time, can differentiate between LTBI and active TB. LIOSpot® TB human is protected by international patents of LIONEX.
1.https://pubmed.ncbi.nlm.nih.gov/29856871/
2.https://pubmed.ncbi.nlm.nih.gov/23029377/
LIONEX Tuberculosis antigens, Mycobacterial antigens
LIONEX has greatly expanded the number of recombinant and native antigens of Mycobacterium tuberculosis.which are now available to the scientific community. All products of LIONEX are exclusively produced by LIONEX in Germany.
Well known antigens are: ESAT6, CFP10, Ag85B, 16kD (Alpha Crystalline, HSP), ALADH, HSP70, HSP65, HSP60, MPT64, MPT70, MPT85, LAM, LAM+LM+PIM, PIM, 19 kDaantigen (Rv3763), PstS1antigen (Rv0934), PstS3antigen (Rv0928), Antigen 85ARv3804c, Antigen MPT51 (Rv3803c), NarL (Rv0844c), Apa (Rv1860), SigC (Rv2069), SigJ (Rv3328c), GlnA1 (Rv2220), HSP20 (Rv0251c), LppO (Rv2290), Tpx (Rv1932), Rv2626c Hrp1, Ppe57 (Rv3425), Ppe58 (Rv3426), Ppe65 (Rv3621c), TB16.3 (Rv2185c), PE35 (Rv3872), BcpB (Rv1608c), HBHA (Rv0475), ICL (Rv0467), CFP7 / TB10.4 (Rv0288), esxS (Rv3020c), whiB1 (Rv3219), KatG (Rv1908), PPE39 (Rv2353c), PPE68 (Rv3873), PPE42 (Rv2608), PPE38 (Rv2352c), DEVR, DOSR (Rv3133c), acg (Rv2032).
Many more are listed in the Catalogue .
LIONEX EndoTrap® HD
is the best affinity product for endotoxin removal from bacteriophage preprations
Read the publication from Finnland on EndoTrap HD, 2019
Lionex Gmbh
World's Leading Producer And Source Of TUBERCULOSIS/ Mycobacterial Antigens For Diagnostics And Vaccine Development
LIONEX is a German biotech company active in the fields of biomedicine and human health with special emphasis on TUBERCULOSIS (TB). Our focus is on research and In-Vitro-Diagnostic (IVD) product development for infectious diseases and cancer. LIONEX has recently launched a new IGRA (Interferon Gamma Release Assay) diagnostic test called LIOFeron®TB/LTBI for LTBI (Latent Tuberculosis Infection). It may also react positive in TB patients also but, as for other similar IGRA tests on the market, it cannot differentiate between LTBI and active TB.
LIONEX is a leading manufacturer of highly purified, endotoxin free, mycobacterial antigens for research on tuberculosis and other mycobacterial diseases.
LIONEX is the licensed, exclusive manufacturer and distributor of a widely known family of endotoxin removal resin under the brand name EndoTrap®. EndoGrade®Ovalbumin is another useful product for research on vaccine development.
Bovine tuberculosis tests are also available for research.
LIONEX has state of the manufacturing facilities for IVD-Lateral Flow Tests. All products are manufactured in Germany. All productions are done under ISO compliant conditions.
We are a highly reliable partner for OEM products for companies active in manufacturing and distribution of such products worldwide.
LIONEX partners and clients are large diagnostic companies, distributors, research institutions, universities, hospitals located on all continents.
If you have any question please contact us
Lionex
© 2018 Lionex GmbH
Last update: Lionex GmbH
LIONEX GmbH
TÜV Rheinland
